This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Innovations by Jose Luis Aceña in Antitumoral Compounds
Introduction
Jose Luis Aceña is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral compounds. His innovative work focuses on new spisulosine derivatives that have potential applications in treating tumors.
Latest Patents
Jose Luis Aceña holds a patent for antitumoral compounds, specifically new spisulosine derivatives. These compounds are characterized by a complex formula that includes various substituents, allowing for a range of applications in cancer treatment. The patent outlines the structural components and variations that can be utilized to enhance the efficacy of these compounds in targeting tumors.
Career Highlights
Throughout his career, Aceña has been associated with Pharma Mar, S.A., a leading biopharmaceutical company. His work at Pharma Mar has positioned him as a key player in the development of innovative cancer therapies. With a focus on research and development, he has contributed to advancing the understanding of antitumoral mechanisms.
Collaborations
Jose Luis Aceña has collaborated with notable colleagues, including Javier Adrio and Carmen Cuevas. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Jose Luis Aceña's contributions to the field of antitumoral compounds exemplify the importance of innovation in cancer treatment. His work continues to inspire advancements in pharmaceutical research and development.